State-Of-The-Art ZLB Behring Plant Licensed By The FDA

4/18/2006 2:33:41 PM

KANKAKEE, Ill.--(BUSINESS WIRE)--April 18, 2006--ZLB Behring today announced that it has been granted a license by the U.S. Food and Drug Administration (FDA) to produce Alpha-1 Proteinase Inhibitor (Human), Zemaira®, in a new facility in its Kankakee, Illinois, manufacturing complex.

Read at press release

Read Article at

Related Companies

News Categories

• press release

• ZLB Behring L.L.C.

• Food and Drug Administration (FDA)

• Biotech/Pharma - Alliances

• Biotech/Pharma - Regulatory